MTNB logo

MTNB Stock Overview

Profile

Full Name:

Matinas BioPharma Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 21, 2014

Indexes:

Not included

Description:

Matinas BioPharma Holdings (MTNB) is a biopharmaceutical company focused on developing innovative therapies for serious diseases. They specialize in lipid-based drug delivery systems to improve the effectiveness and safety of existing medications, aiming to enhance patient outcomes in various medical conditions.

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 3, 2024

Analyst ratings

Recent major analysts updates

Oct 31, 24 Maxim Group
Hold
Jan 31, 23 HC Wainwright & Co.
Buy
Aug 13, 20 Aegis Capital
Buy
Jan 27, 20 Piper Sandler
Overweight
Jan 24, 20 SunTrust Robinson Humphrey
Buy
Jun 26, 19 HC Wainwright & Co.
Buy
Jun 26, 19 H.C. Wainwright
Buy
May 17, 19 BTIG Research
Buy
May 17, 19 BTIG
Buy
Feb 11, 19 Roth Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Matinas BioPharma Holdings?
  • Does Matinas BioPharma Holdings pay dividends?
  • What sector is Matinas BioPharma Holdings in?
  • What industry is Matinas BioPharma Holdings in?
  • What country is Matinas BioPharma Holdings based in?
  • When did Matinas BioPharma Holdings go public?
  • Is Matinas BioPharma Holdings in the S&P 500?
  • Is Matinas BioPharma Holdings in the NASDAQ 100?
  • Is Matinas BioPharma Holdings in the Dow Jones?
  • When was Matinas BioPharma Holdings's last earnings report?
  • When does Matinas BioPharma Holdings report earnings?
  • Should I buy Matinas BioPharma Holdings stock now?

What is the ticker symbol for Matinas BioPharma Holdings?

The ticker symbol for Matinas BioPharma Holdings is NYSE American:MTNB

Does Matinas BioPharma Holdings pay dividends?

No, Matinas BioPharma Holdings does not pay dividends

What sector is Matinas BioPharma Holdings in?

Matinas BioPharma Holdings is in the Healthcare sector

What industry is Matinas BioPharma Holdings in?

Matinas BioPharma Holdings is in the Biotechnology industry

What country is Matinas BioPharma Holdings based in?

Matinas BioPharma Holdings is headquartered in United States

When did Matinas BioPharma Holdings go public?

Matinas BioPharma Holdings's initial public offering (IPO) was on July 21, 2014

Is Matinas BioPharma Holdings in the S&P 500?

No, Matinas BioPharma Holdings is not included in the S&P 500 index

Is Matinas BioPharma Holdings in the NASDAQ 100?

No, Matinas BioPharma Holdings is not included in the NASDAQ 100 index

Is Matinas BioPharma Holdings in the Dow Jones?

No, Matinas BioPharma Holdings is not included in the Dow Jones index

When was Matinas BioPharma Holdings's last earnings report?

Matinas BioPharma Holdings's most recent earnings report was on Nov 13, 2024

When does Matinas BioPharma Holdings report earnings?

The next expected earnings date for Matinas BioPharma Holdings is Mar 27, 2025

Should I buy Matinas BioPharma Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions